PBMCs from RA patients produced more IL-17A than PBMCs from healthy donors with anti-CD3/anti-CD28 stimulation alone, and IL-17A production was further increased with the addition of IL-1β and IL-23 (Fig. 6A). This evidence concerns the gene CD28 and rheumatoid arthritis.